Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf Conversion in Liver Transplant Recipients Based on CYP3A5 Polymorphism
NCT02882113Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2016
- Primary completion
- Aug 2018
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in hepatic dysfunction, sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
hepatic dysfunction
Beyond the preview
Go deeper on NCT02882113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02882113.